See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070494_2023_ACADIA_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001070494, ACADIA PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 507,937,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,021,000 |
| 3 | remainder_Assets | 73,854,000 |
| 4 | LiabilitiesCurrent | 125,630,000 |
| 5 | LiabilitiesNoncurrent | 61,769,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 10,166,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 369,090,000 |
| 9 | ResearchAndDevelopmentExpense | 361,575,000 |
| 10 | remainder_Expenses | 2,531,000 |
| 11 | remainder_Revenues | 517,235,000 |
| 12 | remainder_NetIncome | 10,152,000 |
| 13 | remainder_ComprehensiveNetIncome | -783,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 587,812,000 |
| 1 | Liabilities | 187,399,000 |
| 2 | Expenses | 743,362,000 |
| 3 | Revenues | 517,235,000 |
| 4 | StockholdersEquity | 400,413,000 |
| 5 | NetIncome | -215,975,000 |
| 6 | ComprehensiveNetIncome | -216,366,500 |
| 7 | BaseVar | 1,023,371,500 |
| 8 | EconomicCapitalRatio | 1.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
